Genta pulls Genasense NDA, restructures
GNTA withdrew its NDA for Genasense to treat advanced melanoma. The move follows a 13-3 vote by an
Gathering data...
GNTA withdrew its NDA for Genasense to treat advanced melanoma. The move follows a 13-3 vote by an